110 related articles for article (PubMed ID: 7802444)
21. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06.
Lembersky BC; Wieand HS; Petrelli NJ; O'Connell MJ; Colangelo LH; Smith RE; Seay TE; Giguere JK; Marshall ME; Jacobs AD; Colman LK; Soran A; Yothers G; Wolmark N
J Clin Oncol; 2006 May; 24(13):2059-64. PubMed ID: 16648506
[TBL] [Abstract][Full Text] [Related]
22. [Combined chemotherapy with 5-FU and low dose CDDP for advanced or recurrent cancer of the digestive system and home anti-cancer chemotherapy].
Ogura T; Hiramatsu Y; Araki H; Kojima Y; Nakagawa A; Nakagawa M; Kamiyama Y; Shirasaka T
Gan To Kagaku Ryoho; 1995 Dec; 22 Suppl 4():433-8. PubMed ID: 8849289
[TBL] [Abstract][Full Text] [Related]
23. [Clinical study of ambulatory cancer chemotherapy for advanced colorectal cancer].
Takahashi N; Kunii Y; Ota K
Gan To Kagaku Ryoho; 1995 Dec; 22 Suppl 4():447-52. PubMed ID: 8849291
[TBL] [Abstract][Full Text] [Related]
24. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
Ducreux M; Ychou M; Laplanche A; Gamelin E; Lasser P; Husseini F; Quenet F; Viret F; Jacob JH; Boige V; Elias D; Delperro JR; Luboinski M;
J Clin Oncol; 2005 Aug; 23(22):4881-7. PubMed ID: 16009952
[TBL] [Abstract][Full Text] [Related]
25. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
[TBL] [Abstract][Full Text] [Related]
26. [Clinical analysis of adjuvant chemotherapy using 5-fluorouracil, leucovorin and cis-diamminedichloroplatinum for patients with advanced and recurrent gastric cancer].
Katsumata K; Yamamoto K; Ohno M; Shibata K; Yamashita S; Moriwaki R; Kohno M; Tadatomo H; Koyanagi Y
Gan To Kagaku Ryoho; 1997 Feb; 24(3):309-14. PubMed ID: 9051133
[TBL] [Abstract][Full Text] [Related]
27. Safety of cisplatin combined with continuous 5-FU versus bolus 5-FU and leucovorin, in metastatic gastrointestinal cancer (FFCD 9404 randomised trial).
Duffour J; Bouché O; Rougier P; Milan C; Bedenne L; Seitz JF; Buecher B; Legoux JL; Ducreux M; Vetter D; Raoul JL; François E; Ychou M
Anticancer Res; 2006; 26(5B):3877-83. PubMed ID: 17094417
[TBL] [Abstract][Full Text] [Related]
28. [Cases of advanced cholangiocarcinoma showing partial response by the combination chemotherapy including protracted continuous infusion of 5-FU combined with intravenous administration of low-dose leucovorin and intra-arterial administration of MMC and CQ].
Tsushima K; Sakata Y; Shiratori Y; Sakamoto J; Koeda J; Yamada Y; Soma N; Tamura K; Yoshiwara A; Soma Y
Gan To Kagaku Ryoho; 1991 Dec; 18(15):2603-5. PubMed ID: 1660702
[TBL] [Abstract][Full Text] [Related]
29. Phase I trial of a 5-day infusion of L-leucovorin plus daily bolus 5-fluorouracil in patients with advanced gastrointestinal malignancies.
Valone FH; Gandara DR; Luce JA; Wall S; Perez EA; Braham N; George M; Letvak L
Cancer Chemother Pharmacol; 1993; 32(3):215-20. PubMed ID: 8500227
[TBL] [Abstract][Full Text] [Related]
30. [Comparison between continuous intravenous and oral administration of 5-FU with LV].
Iba T; Kidokoro A; Fukunaga M; Momose F; Fuse S; Nagakari K
Gan To Kagaku Ryoho; 1999 Apr; 26(5):631-5. PubMed ID: 10234293
[TBL] [Abstract][Full Text] [Related]
31. [Efficacy of intra-arterial high-dose leucovorin and 5-FU including combination chemotherapy].
Mitsuhata N; Matsuda T
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3287-90. PubMed ID: 3490831
[No Abstract] [Full Text] [Related]
32. [Clinical evaluation of combination chemotherapy of aclacinomycin A (ACM) and 5-fluorouracil (5-FU) for advanced carcinoma of gastrointestinal tract].
Kikuchi K
Gan To Kagaku Ryoho; 1982 Apr; 9(4):716-21. PubMed ID: 6764110
[TBL] [Abstract][Full Text] [Related]
33. Hand-foot syndrome induced by high-dose, short-term, continuous 5-fluorouracil infusion.
Chiara S; Nobile MT; Barzacchi C; Sanguineti O; Vincenti M; Di Somma C; Meszaros P; Rosso R
Eur J Cancer; 1997 May; 33(6):967-9. PubMed ID: 9291822
[TBL] [Abstract][Full Text] [Related]
34. Leucovorin as a clinical potentiator of 5-fluorouracil toxicity and anticancer efficacy.
Bruckner HW; Spigelman M
Mt Sinai J Med; 1988 Oct; 55(5):390-4. PubMed ID: 3265179
[No Abstract] [Full Text] [Related]
35. [Clinical results of CDDP, MMC and 5-FU combination chemotherapy in advanced or recurrent gastrointestinal cancers].
Sakuyama T; Kimura A; Yoshida S; Yanagisawa S; Soji K; Hano H; Takahashi N; Nagao F
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2796-9. PubMed ID: 3115188
[No Abstract] [Full Text] [Related]
36. Protracted ambulatory venous infusion of 5-fluorouracil.
Lokich J; Fine N; Perri J; Bothe A
Am J Clin Oncol; 1983 Feb; 6(1):103-7. PubMed ID: 6837501
[TBL] [Abstract][Full Text] [Related]
37. The role of UFT in combined-modality therapy.
Blanke CD; Teng M; Choy H
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):47-54. PubMed ID: 10550826
[TBL] [Abstract][Full Text] [Related]
38. Oral fluoropyrimidine-based combination therapy in gastrointestinal cancer.
Vanhoefer U; Wilke H
Oncology (Williston Park); 2001 Jan; 15(1 Suppl 2):79-84. PubMed ID: 11219983
[TBL] [Abstract][Full Text] [Related]
39. A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer.
Vokes EE; Schilsky RL; Choi KE; Magid DM; Guarnieri CM; Whaling SM; Ratain MJ; Weichselbaum RR; Panje WR
Cancer; 1989 Jan; 63(1):30-6. PubMed ID: 2910422
[TBL] [Abstract][Full Text] [Related]
40. [Randomized controlled study of sequential methotrexate and 5-fluorouracil therapy with or without 5'-deoxy-5-fluorouridine against advanced gastrointestinal cancer. Hirosaki Cooperative Study Group for Cancer Chemotherapy].
Yamada Y; Tsushima K; Sakata Y; Saito S; Ito T; Sugimoto N; Ogasawara H; Tamura Y; Moriya N; Komatsu Y
Gan To Kagaku Ryoho; 1994 Jul; 21(8):1187-92. PubMed ID: 8031160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
